The Effects of Gait Speed and Psychomotor Speed on Risk for Depression and Anxiety in Older Adults with Medical Comorbidities
- 2 January 2021
- journal article
- research article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 69 (5), 1265-1271
- https://doi.org/10.1111/jgs.17024
Abstract
Background/Objectives Gait speed and psychomotor speed slow with age and may predict neuropsychiatric disease such as depression and anxiety. We explored the relative predictive values of gait speed, psychomotor slowing, and a composite index of these two measures on time to new episode depression or anxiety in older adults at risk for these common psychiatric conditions. Design Randomized controlled prevention trial with 15‐month follow‐up. Setting University‐based late‐life mental health research clinic. Participants Two hundred thirteen individuals, age 60+ years, with subsyndromal symptoms of depression or anxiety and one of the following risk factors for these common conditions: mild cognitive impairment, knee osteoarthritis, or disabilities requiring home‐based care. Intervention Participants in each of the risk factor groups were randomized to a depression‐specific preventive intervention or usual care. Measurements Gait speed: 4‐m walk test from the Short Physical Performance Battery. Psychomotor speed: Coding task of the Repeatable Battery for the Assessment of Neuropsychological Status. We created a composite index of slowing by determining whether participants exceeded established cut‐offs for slow performance in both gait speed (≤0.8 m/s) and psychomotor speed (P = .046) compared to participants with no slowing in either area. Slowed gait (HR = 1.88; 95% CI = 0.992–3.55; P = .052) or slowed psychomotor speed (HR = 0.60; 95% CI = 0.14–2.58; P = .488) alone did not increase risk for depression/anxiety. Conclusion Evaluating both gait and psychomotor speed in older adults with medical comorbidities and sub‐syndromal depression may predict incident mental illness and inform prevention planning. Future research is needed to validate our observations and explore shared neurobiological mechanisms that explain this elevated risk.Funding Information
- Clinical and Translational Science Institute, University of Pittsburgh (UL1RR024153, UL1TR000005)
- National Institute of Mental Health (MH090333, MH118270)
This publication has 49 references indexed in Scilit:
- The Bidirectional Association between Depressive Symptoms and Gait Speed: Evidence from the English Longitudinal Study of Ageing (ELSA)PLOS ONE, 2013
- Gait Speed and Survival in Older AdultsJAMA, 2011
- The Trajectory of Gait Speed Preceding Mild Cognitive ImpairmentArchives of Neurology, 2010
- Depression in Older AdultsAnnual Review of Clinical Psychology, 2009
- Three-Dimensional Surface Mapping of the Caudate Nucleus in Late-Life DepressionAmerican Journal of Geriatric Psychiatry, 2009
- Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled studyThe British Journal of Psychiatry, 2007
- Cognitive Function, Habitual Gait Speed, and Late-Life Disability in the National Health and Nutrition Examination Survey (NHANES) 1999–2002Gerontology, 2006
- Prognosis of Depression in Old Age Compared to Middle Age: A Systematic Review of Comparative StudiesAmerican Journal of Psychiatry, 2005
- Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double‐blind, randomised 6‐month comparative trial with citalopramInternational Journal of Geriatric Psychiatry, 2004
- CSF amine metabolites in depressionBiological Psychiatry, 1992